会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明公开
    • SINGLE LINKER FABFV ANTIBODIES AND METHODS OF PRODUCING SAME
    • EINZELLINKER-FABFV-ANTIKÖRPERUND VERFAHREN ZUR HERSTELLUNG DAVON
    • EP2935336A1
    • 2015-10-28
    • EP13815506.4
    • 2013-12-20
    • UCB Biopharma SPRL
    • DAVE, EmmaHEYWOOD, Sam PhilipHUMPHREYS, David Paul
    • C07K16/46C07K16/28C07K16/18
    • C07K16/468C07K16/18C07K16/2878C07K2317/55C07K2317/56C07K2317/624C07K2317/64C07K2317/92C07K2319/00
    • The present disclosure relates to a multi-specific antibody molecule comprising or consisting of three polypeptides: a) a polypeptide chain of formula (I): (Vxx)nVx-Cx-X—V1; and b) a polypeptide chain of formula (II): (Vyy)nVy-Cy c) a polypeptide of formula (III):V2 wherein Vx represents a variable domain, Vxx represents a variable domain, Cx represents a constant region, X represents a linker, V represents a variable domain, Vy represents a variable domain, Vyy represents a variable domain, Cy represents a constant region, V2 represents a variable domain, n independently represents 0 or 1, wherein the polypeptide chain of formula (I) and the polypeptide chain of formula (II) is aligned such that the constant regions Cx and Cy are paired and the variable domains Vx and Vy are paired to form a binding domain and optionally a disulphide bond is present between V and V2, in particular where a disulphide bond is present. The disclosure also extends to pharmaceutical formulation comprising the construct, DNA encoding the constructs and vectors comprising same. The disclosure further extends to a method of expressing the constructs, for example in a host cell and methods for formulating same as a pharmaceutical composition. The disclosure also relates to use of the constructs and formulations in treatment.
    • 本公开涉及包含三种多肽或由以下三种多肽组成的多特异性抗体分子:a)式(I)的多肽链:(Vxx)nVx-Cx-X-V1; (II)的多肽链:(Vyy)nVy-Cy c)式(III)的多肽:V2其中Vx表示可变结构域,Vxx表示可变结构域,Cx表示恒定区,X表示 接头,V表示可变结构域,Vy表示可变结构域,Vyy表示可变结构域,Cy表示恒定区,V2表示可变结构域,n独立地表示0或1,其中式(I)的多肽链和 排列式(II)的多肽链使得恒定区Cx和Cy配对,并且可变结构域Vx和Vy配对形成结合结构域,并且任选地在V和V 2之间存在二硫键,特别是其中 存在二硫键。 本公开还延伸到包含构建体的药物制剂,编码构建体的DNA和包含其的载体。 本公开进一步延伸到例如在宿主细胞中表达构建体的方法以及用于配制药物组合物的方法。 本公开还涉及在治疗中使用构建体和制剂。